Bioasis Technologies Inc.
BIOAF
$0.00
$0.00-66.67%
OTC PK
| 11/30/2022 | 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -2.21M | -2.49M | -2.11M | -2.36M | -2.77M |
| Total Depreciation and Amortization | 71.40K | 56.50K | 43.20K | 43.90K | 42.30K |
| Total Amortization of Deferred Charges | 729.80K | 767.90K | 713.70K | 519.70K | 320.10K |
| Total Other Non-Cash Items | -724.10K | -557.20K | -1.14M | -783.30K | 963.30K |
| Change in Net Operating Assets | 627.70K | 295.30K | -228.00K | -323.70K | -305.40K |
| Cash from Operations | -1.50M | -1.93M | -2.72M | -2.90M | -1.75M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -1.24M |
| Cash from Investing | -- | -- | -- | -- | -1.24M |
| Total Debt Issued | 0.00 | 0.00 | 2.91M | 2.91M | 2.91M |
| Total Debt Repaid | -750.00K | -750.00K | -750.00K | -375.00K | 0.00 |
| Issuance of Common Stock | 196.00K | 196.00K | 196.00K | 196.00K | 888.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -90.40K | -90.40K | -90.40K |
| Cash from Financing | -435.80K | -435.80K | 1.82M | 2.12M | 2.96M |
| Foreign Exchange rate Adjustments | 40.50K | 26.20K | 42.40K | -5.10K | -42.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.90M | -2.33M | -854.10K | -790.80K | -70.50K |